Hutchmed begins phase-three trials of lymphoma therapy in China
(Alliance News) - Hutchmed China Ltd on Monday said it had begun phase-three clinical trials of its lymphoma treatment in China. Read More
| Price | 207.00p on 23-04-2026 at 07:45:15 |
|---|---|
| Change | -3.00p -1.43% |
| Buy | 210.00p |
| Sell | 207.00p |
| Last Trade: | Sell 1,328.00 at 207.00p |
| Day's Volume: | 2,694 |
| Last Close: | 210.00p |
| Open: | 211.00p |
| ISIN: | KYG4672N1198 |
| Day's Range | 207.00p - 211.00p |
| 52wk Range: | 192.00p - 292.00p |
| Market Capitalisation: | £1.78b |
| VWAP: | 207.33296p |
| Shares in Issue: | 859.74m |
Sector: Medicine and Biotech
Listed In: FTSE AIM 100, FTSE AIM All-Share,
Hutchmed (HCM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 1,328 | 207.00p | Automatic Execution |
08:37:54 - 23-Apr-26 |
| Sell* | 1,328 | 207.50p | Ordinary |
08:37:31 - 23-Apr-26 |
| Buy* | 9 | 212.00p | SI Trade |
08:09:36 - 23-Apr-26 |
| Sell* | 2,783 | 210.00p | Uncrossing Trade |
16:35:09 - 22-Apr-26 |
| Buy* | 169 | 213.00p | Automatic Execution |
16:23:35 - 22-Apr-26 |
| Buy* | 165 | 213.00p | Automatic Execution |
16:06:16 - 22-Apr-26 |
| Buy* | 3,000 | 212.00p | Ordinary |
16:00:58 - 22-Apr-26 |
| Buy* | 1,292 | 212.247p | Ordinary |
15:45:08 - 22-Apr-26 |
| Sell* | 546 | 212.00p | Automatic Execution |
15:44:22 - 22-Apr-26 |
| Sell* | 1,454 | 212.00p | Automatic Execution |
15:44:22 - 22-Apr-26 |
Hutchmed (HCM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Apr 2026 9:30 am | RNS | 2025 Annual Report and Notice of AGM |
| 9th Apr 2026 7:00 am | RNS-R | Data to be Presented at AACR Annual Meeting 2026 |
| 23rd Mar 2026 7:00 am | RNS-R | HUTCHMED Initiates Phase III Trial of HMPL-760 |
| 16th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 16th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 11th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 11th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 9th Mar 2026 9:30 am | RNS | Update on Licensed Oncology Product in China |
| 6th Mar 2026 8:30 am | RNS | Directorate change |
| 5th Mar 2026 1:00 pm | RNS-R | Publication of Form 20-F |